SION Q2 2025 Earnings — Sionna Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SIONSionna Therapeutics, Inc.

$2B

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$147,000

Operating Income

-$22M

Net Income

-$18M

EPS (Diluted)

$-0.41

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$352M

Total Liabilities

$16M

Stockholders' Equity

$336M

Cash & Equivalents

$41M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$147,000	-$166,000	+11.4%
Operating Income	-$22M	-$11M	-94.0%
Net Income	-$18M	-$9M	-111.3%